Home
About
Overview
Sharing Data
ORCID
Help
History (64)
Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B.
Dissecting the Structural Dynamics of the Nuclear Pore Complex.
Adolescent female with urinary symptoms: a diagnostic challenge for the pediatrician.
Common BRAF(V600E)-directed pathway mediates widespread epigenetic silencing in colorectal cancer and melanoma.
Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma.
See All 64 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma.
Atrash S, Ali SA, Usmani SZ. Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2021 01; 21(1):21-34.
View in:
PubMed
subject areas
Animals
Cell- and Tissue-Based Therapy
Humans
Mice
Multiple Myeloma
T-Lymphocytes
authors with profiles
Saad Usmani MD